title: [Correction of hyperlipidemia with Allicor].
abstract: The hypocholesterolemic action of long-acting garlic powder tablets Allicor was investigated in a double-blind placebo-controlled study in men with mild hypercholesterolemia. Group 1 received allicor in a daily dose 600 mg, group 2 received placebo. The results show that allicor lowers total cholesterol, LDLP cholesterol, raises HDLP cholesterol and therefore can be recommended for correction of lipid content in patients with moderate hyperlipidemia.
authors.forename: I V
authors.initials: IV
authors.lastname: Andrianova
authors.forename: O M
authors.initials: OM
authors.lastname: Demidova
authors.forename: L A
authors.initials: LA
authors.lastname: Medvedeva
authors.forename: O A
authors.initials: OA
authors.lastname: Latyshev
mesh_terms: D000328:Adult; D000368:Aged; D000924:Anticholesteremic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008076:Cholesterol, HDL / Q000097:blood; D008078:Cholesterol, LDL / Q000097:blood; D004334:Drug Administration Schedule; D005737:Garlic; D006801:Humans; D006937:Hypercholesterolemia / Q000097:blood / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D028321:Plant Preparations / Q000008:administration & dosage / Q000627:therapeutic use; D011208:Powders; D016896:Treatment Outcome
chemical_list: D000924:Anticholesteremic Agents; D008076:Cholesterol, HDL; D008078:Cholesterol, LDL; D028321:Plant Preparations; D011208:Powders